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A case of intermittent lumbar pain radiating
to the right shoulder in a 76-year-old woman
(2009: 6b)
Abstract Malignant fibrous histiocy-
toma (MFH) is a pleomorphic sarco-
ma, occurring most frequently in the
deep soft tissues of the extremities,
and it is most frequently seen in
elderly patients. A primary MFH of
the diaphragm is very rare, and to the
best of our knowledge, a multi-phased
spiral CT appearance of this tumour
has not been previously reported. In
this report, we describe the clinical
and multi-phase CT features of a
primary MFH of the diaphragm.
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Introduction
Malignant fibrous histiocytoma (MFH), described by
O’Brien and Stout in 1964, is a pleomorphic sarcoma,
occurring most frequently in the deep soft tissues of the
extremities. It is most frequently seen in elderly patients [1].
A primary MFH of the diaphragm is very rare [2], and to
the best of our knowledge, a multi-phased spiral CT
appearance of this tumour has not been previously reported.
In this report, we describe the clinical and CT features of
a primary MFH of the diaphragm.
Case report
A 76-year-old, non-smoking woman presented with a 3-
month history of intermittent right lumbar pain radiating to
the right shoulder, increasing on deep inspiration. The
patient’s past medical history was characterised by mild
hypertension and gastroesophageal reflux. Physical ex-
amination and routine laboratory investigations were
unremarkable.
Computed tomography of the chest showed a large,
lobulated, well-defined extra-pulmonary soft-tissue mass
(about 8 cm in diameter) located in the base of the postero-
lateral part of the right chest wall. The mass had an
aggressive appearance, being confluent with the diaphragm
and compressing the liver. It invaded ribs and muscles of
the chest wall and caused thickening of the latero-conal
fascia. On unenhanced multidetector CT, it appeared
hypodense compared with the chest wall muscles
(Fig. 1). After injection of iodinated contrast agent, in the
arterial phase, it showed intense early nodular contrast
enhancement, especially just next to peripheral nodules of
the lesion (Fig. 2). During the 4-min-late phase, the lesion
showed a more homogeneous and slightly increased
contrast enhancement than in the arterial phase (Fig. 3).
A fine-needle aspiration biopsy was performed, and
cytological results confirmed a malignant, low-grade soft
tissue tumour.
Removal of the tumour was performed through a
standard right posterolateral thoracotomy, through the
fifth intercostal space. During the operation, the tumour
presented as a fibrous lobulated mass, which originated in
the right hemidiaphragm, involved the adjacent chest wall,
and compressed the liver parenchyma, adhering to
Glisson’s capsule. Through a second incision in the eighth
intercostal space, the patient underwent a wide (4-cm
margin) en-bloc radical resection of the right posterolateral
chest wall, including the 9th to 11th ribs, extended
resection of the right hemidiaphragm, and adherent
Glisson’s capsule. Microscopic confirmation of negative
margins was achieved by frozen section. Reconstruction of
the chest wall and diaphragm defects was performed with
two polytetrafluoroethylene patches. Recovery from the
operation was uneventful.
The results of histological and immunohistochemical
studies confirmed a definitive diagnosis of pleomorphicMFH.
Eight months after surgery, the patient developed a
devastating thromboembolic stroke and died shortly there-
after. At autopsy, the patient was found to have local
recurrence appearing as multiple nodules (less than 1 cm in
diameter) on the surface of the residual pleomorphic MFH
of the right hemi-diaphragm, bordering the lung.
Discussion
Diaphragmatic masses present a radiological challenge
because of their rarity and the difficulty of establishing
exact anatomical relationship with respect to neighbouring
structures, such as the pleura, lungs, spleen or liver where
disease is much more frequent.
Grancher was the first to describe a primary tumour of
the diaphragm, a fibroma, in 1868 [3]. Weiner and Chou
reviewed all reported cases of primary diaphragmatic
tumours from 1868–1963 [4], Olaffson from 1963–1968
[5] and Wekslerfrom from 1968 to 1998 [6].
Diaphragmatic tumours may be benign or malignant.
Diaphragmatic mesothelial cysts are congenital lesions that
derive from coelomic remnant (the coelom is the primitive
cavity that lies within the developing embryo that will form
Fig. 1 From A (cranial) to F (caudal). Large, lobulated, well-
defined extra-pulmonary soft-tissue mass located in base of the
postero-lateral part of right chest wall, indissociable from the
diaphragm and compressing the liver. On basal CT the tumour
appeared slithly hypodense to the chest wall muscles
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the three major body cavities: pericardial, pleural and
peritoneal). They represent the most common benign
tumours, followed by lipomas and neurolemnomas [7].
As far as malignant tumours are concerned, fibrosarco-
mas are the most common, followed by leiomyosarcomas
and rhabdomyosarcomas.
In the literature so far, there are reports of only five cases
of primary malignant fibrous histiocytoma (MFH) originat-
ing in the diaphragm [2, 8]; they all presented as
intrathoracic masses.
MFH is a deep-seated pleomorphic sarcoma of adults
that occurs most frequently in the deep fascia and
skeletal muscles of the extremities and the trunk. But
there are reports of MFH occurring also in the head and
neck region, brain, chest wall, lung, heart, intestinal tract
and mesentery [9].
It was first documented in 1964 by O’Brien and Stout
[10], who considered it to have a histiocytic origin. There
has been a lot of controversy over the histogenesis for
several decades, but it still remains uncertain [9]. One of
the theories advanced is that it might originate from
primitive mesenchymal cells, which have the capacity for
multidirectional differentiation. This could also explain
why MFH can occur at any location and has a diversified
histological morphology [11, 12].
MFH is aggressive with a propensity for local recurrence
and distant metastasis [13, 14]. Tumour size is a factor that
seems to influence the rate of local recurrence or metas-
tasis, the prognosis of MFH being worse in patients with
tumours larger than 5 cm in diameter [2, 14, 15].
The majority (60%) of MFHs are classified as the
storiform-pleomorphic subtype; they are pleomorphic
sarcomas that contain both fibroblast-like and histiocytic-
like elements in varying proportions, thereby manifesting a
spectrum of histological appearances [13, 16].
Characteristically, the plump spindle cells are arranged
in a cartwheel-like appearance around vessels forming
peripheral nodules that are typical of the pleomorphic form
[1]. On a pretherapeutic CT study calcifications are uncom-
mon prior to chemotherapy.
After administration of contrast material, there is often
nodular and peripheral arterial enhancement of the solid
(pleomorphic) elements [1, 18] due to an abundant
capillary network. Our case also, in late venous phase (4
Fig. 2 From A (cranial) to F (caudal). After injection of iodinated contrast agent, in the arterial phase, contrast enhancement is seen within
peripheral lesion nodules
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min after contrast agent injection), shows persistence of
slight and homogeneous contrast enhancement.
The second most common subtype (25%) is the myxoid
variant. It is characterised by a prominent myxoid appear-
ance to the stroma. Myxoid tissue is generally hypocellular.
Typically, on CT scans it presents a low density central area
because of a large amount of mucous material, such as
haemorrhage or necrosis [1, 17, 18].
Occasionally the appearance of myxoid MFHs, particu-
larly those with more vascular and cellular elements, is less
specific on CT images, with a more homogeneous soft-
tissue appearance being seen both before and after contrast
material administration.
Diaphragmatic MFHs, which occur in older adults, have
to be distinguished from the other most common malignant
diaphragmatic tumours, such as fibrosarcoma, which is
isodense to the muscles in plain CT.
Leiomyosarcoma has a spindle shape and after intrave-
nous contrast material typically exhibits an enhanced
peripheral rim and a quite large central area of low
attenuation. Differential diagnosis with pleomorphic MFH
is quite easy due to the absence of peripheral enhanced
nodules in leiomyosarcoma. Otherwise, it is similar to
myxoid MFH because of central large hypocellular areas,
but leiomyosarcoma typically occurs in young people.
Rhabdomyosarcoma occurs usually in people younger
than 45 years of age and has areas of necrosis that do not
enhance after contrast injection and that can alternate with
areas of marked enhancement [17].
A diaphragmatic lesion has to be distinguished from a
localized pleural malignant mesothelioma, which has
calcifications and shows a slight contrast enhancement.
Finally, the appearance of diaphragmetic liposarcoma
varies from a predominantly fat-containing mass to a solid
mass: low attenuation values around −50 Hounsfield units
are consistent with a tissue composed of fat; greater values
are related to the necrosis, heterogeneity and soft tissue
component in liposarcomas [19].
As far as we can ascertain, this is the first report of a
dynamic multi-phase multidetector CT study of a primary
diaphragmatic MFH.
Although the definitive diagnosis of MFH is histological,
multi-phase CT is useful for diagnosing the presence of a
tumour and its characterisation in the diaphragm because
detection of peripheral nodules with intense contrast enhance-
ment in arterial phase could be useful for diagnosing MFH.
Fig. 3 From A (cranial) to F (caudal). During the 4-min-late phase, the lesion showed a more homogeneous contrast enhancement than in
the arterial phase
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